Assessment of the relative effectiveness of erenumab compared with onabotulinumtoxinA for the prevention of chronic migraine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessment of the relative effectiveness of erenumab compared with onabotulinumtoxinA for the prevention of chronic migraine

Published:2022-10-13 Issue:1 Volume:39 Page:105-112
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Mahon Ronan¹,Vo Pamela²,Pannagl Katharina³,Tiwari Santosh⁴,Heemstra Harald²,Ferraris Matias²,Zhao Jing⁵,Betts Keith A.⁵,Proot Pascal⁶

Affiliation:

1. Novartis Ireland Limited, Dublin, Ireland

2. Novartis Pharma AG, Basel, Switzerland

3. Novartis Pharmaceuticals UK Limited, London, UK

4. Novartis Healthcare Private Limited, Hyderabad, India

5. Analysis Group, Inc, Los Angeles, CA, USA

6. Ghent University Hospital, Ghent, Belgium

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2022.2131299

Reference62 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

2. Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019

3. Migraine prevalence by age and sex in the United States: A life-span study

4. Managing Bardet–Biedl Syndrome—Now and in the Future

5. International Classification of Headache Disorders - ICHD-4 alpha

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical effectiveness of pharmacological interventions for managing chronic migraine in adults: a systematic review and network meta-analysis;The Journal of Headache and Pain;2023-12-06

2. Chronic Migraine as a Primary Chronic Pain Syndrome and Recommended Prophylactic Therapeutic Options: A Literature Review;Life;2023-02-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3